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57 ABSTRACT 
Bovine cell line resistant to infection by the pestiviruses 
Bovine Viral Diarrhea Virus (BVDV), Hog Cholera Virus 
(HCV) and Border Disease Virus (BDV) and all progeny and 
mutants thereof. A bovine cell line (CRIB) that is resistant 
to infection by cytopathic and non-cytopathic BVDV and by 
other Pestiviruses due to a stable, recessive genetic defect 
which blocks infection at the level of viral entry. 
4 Claims, No Drawings 
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1. 
BOVINE CELL LINE RESISTANT TO IN 
VTRO INFECTION BY BOVINE WRAL 
DARRHEAVIRUS AND ALL OTHER 
KNOWN PESTIVIRUSES 
GOVERNMENT RIGHTS 
The present invention was partially funded by CSRS 
contract i2-37204-7959. 
A portion of the disclosure of this patent document 10 
contains material which is subject to copyright protection, 
The copyright owner has no objection to the facsimile 
reproduction by anyone of the patent document or the patent 
disclosure, as it appears in the Patent and Trademark Office 
patent file or records, but otherwise reserves all copyright 15 
rights whatsoever. 
CROSS REFERENCES 
Related Applications 
The present application is an original patent application 
and is currently not known to be related to any co-owned and 
co-pending application. 
TECHNICAL FIELD 25 
The present invention is the first bovine cell line reported 
to be resistant to in vitro infection by bovine viral diarrhea 
virus (BVDV) and all other known viruses belonging to the 
genus Pestivirus. These cells, designated CRIB cells (cells 
resistant to Bovine Viral Diarrhea Virus) may be useful tools 30 
for studying the early interactions of pestiviruses with host 
cells. Furthermore, CRIB cells may have important appli 
cations in basic research, diagnostic virology and for pro 
duction of BVDV-free biologicals in bovine cells. 
35 
BACKGROUND ART 
Bovine viral diarrhea virus (BVDV) is an enveloped virus 
of cattle with a single-stranded RNA genome 12.5 kb in 
length. The naked viral RNA is infectious upon transfection 
into permissive cells, being translated into a single 3988 
amino acid polyprotein that is co- and post-translationally 
processed by viral and cellular proteases. BVDV is currently 
classified within the Flaviviridae family, being a member of 
thc genus Pestivirus, along with the hog cholera virus (HCV) 45 
and border disease virus (BDV). 
Bovine viral diarrhea virus naturally infects cattle, ovine, 
swine, caprine, buffalo and a wide variety of wild ruminants, 
all members of the order Artiodactyla. BVDV replicates in 
tissue culture cells from these species and has been often 50 
found contaminating cells from other non-related species. 
All known bovine cell lineages and primary cultures are 
susceptible to BVDV infection in vitro. In contrast, only 
selected cell populations have been shown to be infected in 
vivo. The reasons for the difference between the narrow 55 
tissue tropism in vivo and the wide cell range in vitro are not 
understood, but constitute a fundamental issue for the under 
standing of viral pathogenesis. It is likely that this difference 
in tissue tropism is derived from differential expression of 
host cell molecules that modulate virus replication and 60 
spread. The identification of host cell factors modulating 
virus replication may lead to the understanding of the 
molecular basis of virus host range and tropism. 
The detailed mechanism(s) of BVDV entry into suscep 
tible cells are unknown but certain general aspects have been 65 
elucidated. Some evidence suggests that BVDV, like other 
members of the Flaviviridae, initiate infection by a mecha 
40 
2 
nism of receptor-mediated endocytosis, followed by low 
pH-dependent fusion of the virus envelope with the endo 
somal membrane. The BVDV envelope glycoproteins EO 
(gp 48) and/or E2 (gp53) are believed to participate in the 
initial interactions of virions with cells. The major glyco 
protein E2 (gp 53) is likely to play a major role in attach 
ment/penetration since most monoclonal antibodies directed 
against E2 are neutralizing. Cell surface molecule(s) inter 
acting with viral envelope glycoproteins to bring about 
BVDV entry have not been identified and characterized. 
Monoclonal antibodies directed against bovine cell surface 
proteins have been shown to partially inhibit BVDV infec 
tion, but their molecular specificity remains unknown. In 
addition, anti-idiotypic antibodies mimicking the BVDV E2 
(gp53) have been shown to partially prevent infection with 
some strains of BVDV in MDBK cells (Xue & Minocha, 
1993, "Identification of the cell surface receptor for bovine 
viral diarrhea virus by using anti-idiotypic antibodies." J. 
Gen. Virol. 74: 73-9). These data taken together suggest that 
multiple receptors or BVDV may exist and that different 
strains may use different receptors to initiate infection 
(Collett et al., 1989 "Comparisons of the pestivirus bovine 
viral diarrhea virus with members of the flaviviridae.' J. 
Gen. Virol. 69:2637–43; Xue & Minocha, 1993, supra). 
Hog cholera virus (HCV, also known as classical swine 
fever in European countries) is a member of the genus 
Pestivirus, within the family Flaviviridae, as described in the 
5th Report of the International Commission on Taxonomy of 
viruses. The virus shares a number of biological properties 
with the other two members of the genus: BVDV of cattle 
and Border Disease Virus of sheep. They have similar host 
ranges in vivo and in vitro. They may also cause transpla 
cental infections in heterologous hosts; e.g. BVDV can 
infect pigs and HCV may infect cattle. However, infection of 
heterologous animal hosts with a Pestivirus does not result 
in acute disease. The overall genetic relatedness among the 
Pestiviruses is well defined by the extent of nucleotide 
sequence homology between the genomes of the virus 
species in this genus: 60-70%. Some strains of HCV are 
highly virulent, and can cause extremely high mortality rates 
in susceptible swine populations. This virus was eradicated 
from the U.S. in the 1970's. Harkness, J. W. (1985), "Clas 
sical swine fever and its diagnosis: A current view.’ Vet. Rec. 
288-293; Collett, M. S., Moennig, V., and Horzinek, M., 
"Recent advances in Pestivirus Research.” (1989) J. Gen. 
Virol.., 70:253-266. 
Border disease virus of sheep is a Pestivirus responsible 
for the hairy-shaker syndrome in lambs, also known as 
Border Disease. The syndrome is a consequence of the fetal 
infection which causes congenital neurologic and tegument 
defects. The virus appears to be unable to cause severe acute 
disease, in contrast with the bovine and swine Pestiviruses. 
Moennig, V., "Pestiviruses: A Review." Wet. Microbiol. 
23(1-4): 35-54. The virus is present in the U.S. but its 
economic importance is commensurate with that of the 
sheep industry. The biology of the Border Disease virus is 
similar to that of BVDV, sharing -70% nucleotide sequence 
homology between genomes. P. Becher, et al "Molecular 
Characterization of Border Disease Virus, a Pestivirus From 
Sheep." Virology (1994) 198:542-51. 
In 1988, House, USDA, et al reported a porcine kidney 
cell line IB-RS-2 Clone D10 (IB-RS-2 D10) which was said 
to be resistant to infection by both hog cholera virus (HCV) 
and BVDV (House, et al., 1988, "Characteristics of the 
Porcine Kidney Cell Line IB-RS-2 Clone D10 (IB-RS-2 
D10) Which is Free of Hog Cholera Virus' In Vitro Cell. 
Dev. Bio. 24:677-682). After cloning, it was tested exten 
5,541,102 
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sively and judged to be free of HCV based upon the results 
of the tests available at that time. Based on these results, 
USDA authorized ATCC to distribute IB-RS-2 D10. How 
ever, in 1993, as part of an ongoing program to test cell lines 
for the presence of Bovine Viral Diarrhea Virus, ATCC 
tested this cell line and found it to be infected with HCV. It 
is believed that the parent cell line from which the D10 clone 
was derived was itself infected with HCV and the cloning 
performed by House reduced the HCV to levels that were 
not detectable by the tests performed at that time, but with 
subsequent passages, the virus multiplied to the point where 
it became detectable. The resistance to BVDV infection 
exhibited by the D10 clone is not a true resistance. Instead, 
the presence of hog cholera virus in the D10 cell caused the 
cell to exhibit interference when the cells are inoculated with 
cytopathic BVD virus. The cytopathic effect was delayed 
and the viral titer was low after infection. The viral inter 
ference phenomenon exhibited by the host cholera virus in 
B-RS-2 D10 line accounts for its apparent "resistance' to 
BVDV infection. However, the phenomena of interference is 
not the same as a cell line being refractory to infection with 
BVDV. (See Malmquist, et al., “Interference of Bovine Viral 
Diarrhea Virus by Hog Cholera Virus in Swine Kidney Cell 
Cultures. Am. J. Vet. Res. 26(115): 1316–1327 (1965).) 
Therefore, while efforts have been made to identify a cell 
line resistant to in vitro BVDV infection, these efforts have 
failed heretofore. 
DISCLOSURE OF INVENTION 
We have isolated, cloned and characterized a novel bovine 
cell line, referred to as CRIB, that is resistant to infection 
with BVDV and all other known viruses of the genus 
Pestivirus. The clone designated CRIB-1 was deposited at 
the American Type Culture Collection (Rockville, Md.) on 
Jul. 6, 1993 under Accession No. SD 1831. CRIB cells were 
derived from the well characterized Madin-Darby Bovine 
Kidney (MDBK) cell line (ATCC, CCL-22) through cloning 
of cells surviving multiple rounds of infection with a highly 
cytolytic BVDV strain. The selected clones were shown to 
be free of infectious BVDV or subviral products by indirect 
immunofluorescence, cocultivation, animal inoculation, 
northern and southern blot hybridization and RNA PCR. 
Repeated challenge of CRIB cells with several cytopathic 
and non-cytopathic BVDV strains does not result in infec 
tion as demonstrated by immunofluorescence and coculti 
vation. Challenges made with isolates of hog cholera virus 
and border disease virus, the other known members of the 
Pestivirus genus, also did not result in infection. Microsat 
ellite DNA PCR, karyotyping and isoenzyme analysis have 
demonstrated that CRIB are genuine bovine cells. CRIB 
cells are susceptible to other bovine viruses like the parental 
MDBK cells. The genetic defect of CRIB cells is stable and 
recessive: somatic cell hybrids of CRIB with bovine lym 
phocytes are susceptible to BVDV infection and produce 
infectious virus. Transfection of CRIB cells with BVDV 
RNA or virus inoculation in the presence of polyethyleneg 
lycol (PEG) result in productive infection. Therefore, the 
defect of CRIB cells is at the level of virus entry. 
Therefore, it is a primary object of the present invention 
to provide a bovine cell line resistant to in vitro BVDV 
infections and to infection by all other known viruses of the 
genus Pestivirus. Another object of the present invention is 
to provide cells which may be utilized to study the early 
interactions between pestiviruses and their host cells. Yet 
another object of the present invention is to provide CRIB 
cells which may be utilized in diagnostic virology to identify 
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4. 
the host factors mediating BVDV infection as well as for 
production of BVDV-free biologicals in bovine cells. These 
cells may also be used to clone the cellular molecule 
required for entry of BVDV, hog cholera virus and border 
disease viruses into cells. These and other objects will be 
apparent to the art upon reading the specification. 
DETALED DESCRIPTION 
Experimental Procedures to Assay Resistance to 
BVDV 
The results of experiments presented herein and summa 
rized in Table 1 below indicate that the resistance exhibited 
by the CRIB cell line is the result of the absence of a 
common cell surface factor that is required to mediate virus 
entry/uncoating by most, if not all, BVDV strains in MDBK 
cells. 
TABLE 1. 
Methods used to detect infectious 
BVD virus and viral products in CRIB cells. 
Assay Result 
Indirect Immunofluorescence (IFA) Negative 
Cocultivation Negative 
Animal inoculation Negative 
Northern Blot Negative 
Southern Blot Negative 
RNA PCR Negative 
1. Cells and Viruses 
Madin-Darby Bovine Kidney (MDBK, CCL-22) cells 
were obtained from the American Type Culture Collection 
(ATCC, Rockville, Md.) at passage 110 and routinely cul 
tured for approximately 25 passages. The source of other 
cell lines used in the BVDV host range experiments is 
shown in Table 2. Cells were maintained in Eagle's mini 
mum essential medium (MEM) (Gibco Labs, New Island, 
N.Y.) supplemented with 5% fetal horse serum (Sigma 
Chem. St. Louis, Mo.), penicillin and streptomycin (Sigma 
Chem.). BL-3 cells were cultured in RPMI medium supple 
mented with 10% of gamma-irradiated fetal bovine serum 
(Gibco Labs). 
The source of the BVDV isolates is shown in Table 3. 
Stocks of BVD virus were produced in bovine testicle cells, 
quantitated and stored at -70° C. The other bovine viruses 
were obtained from the Veterinary Diagnostic Laboratory, 
University of Nebraska Lincoln, Lincoln, Nebr. 
2. Monoclonal Antibodies (Mabs) and Immunofluores 
cence Assays 
Murine monoclonal antibodies (mabs) 4, 12, 19 and 20 
are specific for distinct epitopes of the major BVDV enve 
lope glycoprotein gp53 (E2) and mab 15 is specific for the 
envelope glycoprotein gp 48 (EO) (Donis & Dubovi, 1987). 
Bovine anti-BVDV polyclonal antisera was produced as 
previously described (Donis & Dubovi, 1987). Fluorescein 
isothiocyanate (FITC)-conjugated antibovine parvovirus 
antisera was obtained from the National Veterinary Services 
Laboratory (NVSL, Ames, Iowa). 
Indirect immunofiuorescence (IFA) for BVDV antigens 
was performed using a mixture of mabs 4, 12, 15, 19 and 20 
(oligoclonal) or polyclonal antisera as primary antibody and 
a FTC-conjugate goat anti-mouse or anti-bovine IgG mono 
clonal antibody (Boeringher Manhein, Inc.) as secondary 
antibody. IFA was performed 24 hours post-infection (hpi) 
5,541,102 
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for cytopathic and 36 hpi for non-cytopathic BVDV strains. 
Direct immunofluorescence of cells inoculated with bovine 
parvovirus was performed 48 hpi. 
3. BVDV Infection and Cloning of Surviving MDBK 
Cells-Establishment of a Bovine Cell Line Resistant to 
Bovine Wiral Diarrhea Virus Infection 
MDBK cells (5x10') were infected with approximately 
10 TCIDso?cell of a cytopathic BVDV strain (Singer-cp) and 
medium was changed every 3 days until survivor cells grew 
up to form colonies (approximately 6 weeks). Infection of 
bovine cells with cytopathic BVDV at high m.o.i. usually 
results in lysis of nearly 100% of the cells. However, 
occasional surviving cells may give rise to a persistently 
infected culture. Following infection of MDBK cells with 
m.o. i. of 10 TCIDs of BVDV Singer-cp, a few cells 
survived and were cultured for six weeks until they formed 
colonies and could be trypsinized and subcultured. During 
this time, the cells alternated periods of growth with periods 
of crisis in which nearly the entire monolayer showed 
characteristic BVDV-induced vacuolation and died. 
Throughout several periods of growth and crisis, some cell 
lineages were being selected that no longer showed cytopa 
thology and grew up to form colonies. Indirect immunof 
luorescence (IFA) performed at the time of the first subcul 
ture showed that almost the totality of the cells were 
negative for BVDV antigens. To test the susceptibility of the 
cells lacking BVDV antigens, the cells were re-infected with 
BVDV Singer-cp and processed for IFA. After confirmation 
that the cells devoid of BVDV antigens were resistant to 
infection with BVDV, they were cloned out by limiting 
dilution and 20 independent clones were obtained. The 
survivor cells, designated CRIB (Cells resistant to Infection 
with BVDV), were cloned out by limiting dilution and 
cloncs derived from a single cell were propagated. Twenty 
clones, named CRB-1 to 20, were selected, propagated and 
stored in liquid nitrogen. The initial experiments performed 
to detect BVDV antigens by IFA and cocultivation were 
carried out with the uncloned population of cells and with all 
twenty clones (CRIB-1 thru CRIB-20). The subsequent 
cxperiments utilized the cells from clone 1 (CRIB-1). 
4. Assays for the Detection of Infectious BVD Virus and 
Viral Subproducts in CRIB Cells Show that CRIB Cells 
Contain no Infectious BVD Virus or Viral Subproducts 
As CRIB cells were derived from cells that survived 
infection with BVDV and had been cultured in the presence 
of virus for up to six weeks, it would be expected that they 
might still support low levels of virus replication or contain 
residual viral RNA. Therefore, the resistance to infection 
could be explained by the presence of replication-competent 
viral RNA that would interfere with replication of the 
homologous virus. Different approaches were taken to 
investigate if CRIB cells contain infectious virus or vital 
remnants. The presence of BVDV antigens in CRIB cells 
was monitored by IFA as described above. Production of 
infectious virus by CRIB cells was assessed by cocultivation 
with indicator bovine testicle cells and animal inoculation: 
(a) Cocultivation: CRIB and bovine testicle cells were 
trypsinized, mixed in a ratio of 1:1 and cultivated for up to 
4 weeks. Cells were subcultured twice a week and produc 
tion of BVDV antigens was monitored by IFA using a 
mixture of BVDV-specific monoclonal antibodies. Indirect 
immunofluorescence (IFA) using polyclonal antisera and a 
panel of monoclonal antibodies against structural and non 
structural proteins has failed to detect BVDV antigens in 
these cells. Likewise, cocultivation of CRIB with bovine 
testicle cells for up 4 weeks did not reveal production of 
infectious virus. (b) Animal inoculation: approximately 2.5.x 
10. 
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10' CRIB-1 cells were inoculated intravenously in an eight 
months-old, BVDV-seronegative calf. Blood samples for 
serology were taken before inoculation and 2 and 4 weeks 
post-inoculation. Heat inactivated (56° C. for 30 minutes) 
serum samples were submitted to serum-neutralization 
assays as described elsewhere (Rossi & Kiesel, 1971). The 
serum-neutralization assays performed on blood samples 
collected 4 weeks after inoculation showed that the animal 
remained seronegative for BVDV attesting to the lack of 
production of infectious BVD virus by CRIB cells. 
CRIB cells were also shown to be free of residual BVDV 
genetic material (RNA) by means of northern blot and RNA 
PCR. Also, a possible integration of DNA copies of the viral 
RNA into the cell chromosomes was investigated by south 
ern blot hybridization, giving negative results. (a) Northern 
blot: total RNA extracted from CRIB-1, BVDV-infected and 
mock-infected MDBK cells was separated in a denaturing 
1% agarose gel, blotted onto a nitrocellulose membrane, 
prehybridized and hybridized according to standard proto 
cols (Ausubel et al., 1986). (b) Southern blot: CRIB-1 and 
MDBK genomic DNA was extracted by a salting out method 
(Miller et al., 1988), digested overnight with 2 U/Mg of 
EcoRI, BamHI and HindIII (Promega) electrophoresed in an 
1% agarose gel and blotted onto a nitrocellulose membrane. 
Prehybridization and hybridization were performed as pre 
viously described (Ausubel et al., 1986). The nitrocellulose 
membranes were hybridized with 'P labeled DNA probe 
(oldATP, Amersham, Inc.) synthesized by random priming 
(Feinberg & Vogelstein, 1983) of a 1531 bp HindIII/BgIII 
DNA fragment of the plasmid PBSD 2.3 that corresponds to 
the NS5 (p75) region of the BVDV NADL strain (Collet et 
al., 1988) and exposed to a Kodak-X-Omat film. (c) RNA 
PCR: A set of two 14-mer primers was used to amplify a 
target sequence of 323 bp from the p75 region of the BVDV 
genome. Total cellular RNA from approximately 5x10 
CRIB-1, BVDV-infected and mock-infected MDBK cells, 
contained in 2 ul, were used as template. Total cell RNA was 
extracted as described below and reverse transcription was 
performed as previously described (Lopez et al., 1991 ) 
using avian myeloblastosis virus (AMV) reverse tran 
scriptase (Life Sciences, Inc.). The PCR conditions were as 
follows: 1 minute denaturation at 95°C.; 1 minute annealing 
at 34° C. and 3 minutes extension at 56° C. in a total of 35 
cycles. PCR products were analyzed by agarose gel elec 
trophoresis in a ethidium bromide-stained 1% agarose gel. 
Specificity of RNA PCR amplification was ascertained by 
southern blot hybridization, using the same probe described 
above. 
Taken together, these results demonstrate that CRIB cells 
are free of BVD virus or viral subproducts. Furthermore, the 
lack of detection of residual BVDV RNA indicates that 
resistance to infection is not derived from homologous 
interference. 
5. Assays for BVDV Susceptibility Show that CRIB Cells 
are Resistant to BVDV Infection 
Initially, CRIB-1 and MDBK cells were inoculated with 
BVDV Singer-cp and VS115ncp at multiplicities of infec 
tion (m.o.i.) ranging from 1 to 100 TCIDso Infection was 
monitored by indirect immunofiuorescence (IFA) and by 
passage of supernatant of cultures in bovine testicle cells. 
Production of infectious virus by CRIB-1 cells following 
inoculation with BVDV Singer-cp and VS115-ncp was 
further monitored by cocultivation with indicator bovine 
testicle cells. Cocultivation was performed as described 
above with the following modifications: after adsorption of 
the virus inoculum for one hour at 37° C. and washing 
unbound virus, remaining extracellular virus was neutralized 
5,541,102 
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by addition of a mixture of neutralizing mabs or anti-BVDV 
polyclonal antisera for 72 hours. Following extracellular 
virus neutralization, CRIB-1 cells were trypsinized, mixed 
and cultured with bovine testicle cells. The cocultures were 
maintained up to 2 weeks and infection of indicator cells was 
monitored by IFA. Infected MDBK cell controls were 
included to ascertain the inability of the neutralization step 
to clear intracellular virus in infected MDBK cells. 
The BVDVinoculation experiments, using Singer-cp and 
VS115-ncp at m.o.i. ranging from 0.1 to 100 TCIDso were 
repeated multiple times and CRIB cells have been consis 
tently shown to be refractory to BVDV infection (Table 2). 
Inoculation of CRIB cells with these BVDV strains at m.o.i. 
of approximately 10 TCIDso did not cause appearance of 
infected cells when tested by IFA. In addition, we were 
unable to detect production of infectious virus by 10 CRIB 
cells after inoculation of 1 TCIDso of VS115ncp followed by 
cocultivation with susceptible cells. 
TABLE 2 
Susceptibility of MDBK and CRIB cells to infection 
with bovine viral diarrhea virus (BVDV) 
Strain? Reference? Bio 
Isolate origin type MDBK CRIB 
Singer McClurkin, 1974 cp -- r 
NADL Gutenkust & Malmquist, 1964 cp -- - 
Cpl. Meyers at al., 1991 cp -- - 
NCP-1 Meyers et al., 1991 Cp -- - 
WS115 Donis, unpublished incp -- - 
WS14a Nebraska ncp -H - 
VS8a Dubovi, unpublished incp -- - 
VS83 Dubovi, unpublished cp -H - 
WS53a Dubovi, unpublished cp -- - 
VS22 Oregon cp -H -- 
VS186 Dubovi, unpublished cp -- r 
WS60 Maryland cp -- - 
WS2 Tennessee cp -H -- 
VS21 Bolin, AJVR. 52: 1033 Cp -- - 
VS15 Bolin, AJVR 52: 1033 incp -- - 
VS84 Dubovi, unpublished cp -- - 
WS91 Dubovi, unpublished cp -- - 
VS46 Dubovi, unpublished cp rer 
VS110 Dubovi, unpublished cp - r 
VS182 Dubovi, unpublished ncp -. - 
VS183 Dubovi, unpublished incp -- - 
VS184 Dubovi, unpublished Ilcp -- - 
VS191. Donis, unpublished incp -- - 
VS192 Donis, unpublished incp -- - 
Inoculation experiments using m.o.i. of 50 or higher 
occasionally resulted in detection of rare IFA positive CRIB 
cells. The frequency of infection of CRIB cells upon chal 
lenge with 50 TCID50/cell of cytopathic BVDV strains has 
been estimated to be around 10. These occasional infected 
cells appear not to transmit virus by cell-to-cell spread since 
no infected cell foci were found. This indicates that a very 
high m.o.i. is required to obtain a few infected cells but 
amplification of virus by multiple cycles of infection does 
not take place. Nonetheless, it is possible that occasionally 
infected cells may produce infectious virus that would 
eventually be detected by cell inoculation or cocultivation. 
To ascertain the range of resistance of CRIB cells to 
different strains, CRIB-1 and MDBK cells were inoculated 
with each of the 24 BVDV isolates, including prototype 
strains and field isolates at a m.o. i. of approximately 1, and 
infection was monitored by IFA, using oligoclonal mabs, as 
described above (Table 2). We were unable to detect BVDV 
antigens in CRIB cells by IFA following inoculation with 
any of the BVDV isolates tested. 
These results taken together demonstrate that CRIB cells 
are resistant to BVDV infection. CRIB cells are approxi 
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mately 10 more resistant to BVDV infection than their 
parental MDBK cells. Neither viral protein synthesis nor 
production of infectious virus have been detected in CRIB 
cells upon virus inoculation, thus we consider this cell line 
to be resistant to BVDV infection. The approximately 10 
frequency of infection represents artifactual paths of virus 
entry when very high m.o.is are used. Furthermore, no one 
of the 24 isolates tested was able to infect CRIB cells, yet 
infecting more than 75% of MDBK cells, suggesting that the 
BVDV resistance in CRIB cells is not a virus strain 
dependent phenotype. 
6. BVDV in Vitro Host Range 
To determine if the BVDV resistant phenotype of CRIB 
cells represents a unique event among bovine and cell lines 
from closely related species (order Artiodactyla), we per 
formed BVDV infection experiments including different 
primary and established cell lines from these species (Table 
3). 
A number of primary or established cell lines of bovine 
and non-bovine origin were inoculated with approximately 
1 TCIDs/cell of each of 6 BVDV strains and infection was 
monitored by IFA and passage of culture supernatant. 
BVDV- and mock-infected MDBK cells were used as con 
trols. The results of this BVDV in vitro host range trial are 
shown in Table 3. The frequency of positive cells by IFA 
ranged from about 3-5% in swine PK-15 cells infected with 
cp BVDV to over 80% for almost all bovine cells infected 
with any of the strains. Ovine and goat cells were susceptible 
at levels comparable to those of bovine cells. Interestingly, 
primate (CV-1 and Veto) and feline cells (CRFK) were also 
found to be permissive to expression of BVDV antigens. 
TABLE 3 
Susceptibility of cells of species from the order 
Artiodactyla to bovine viral diarrhea virus (BVDV) infections" 
cell species organ type SOCe 
BL bovine lung primary VDCb 
BT bovine nasal turbinate cell line VDCb 
RD-420 bovine testicle SW40 transf. R 
RD-9 bovine testicle primary RD 
MDBK bovine kidney cell line ATCC 
CPA-47 bovine endothelium cell line ATCC 
EbTr bovine trachea cell line ATCC 
A4 bovine adrenal primary GD/Cd 
Bi bovine brain primary GDICJ 
C3 bovine cerebellum primary GD/Cd 
BI-3 bovine lymphocyte BLV JRf 
transformed 
Lymphocytes bovine lymphocyte primary RD 
pT swine testicle ce line ATCC 
PK-1 swine kidney primary VDCb 
PK-15 swine kidney cell line ATCC 
GT caprine testicle cell line ATCC 
ESLCH caprine esophagus cell line ATCC 
MDOK bovine kidney cell line ATCC 
As determined by indirect immunofluorescence at 20–24 h post infection 
for cp BVDV and 30-36 h for ncp BVDV using oligoclonal antisera as 
primary antibody and FITC conjugated anti-mouse IgG monoclonal antibod 
ies as secondary antibody. 
Origin of cells: 
Veterinary Diagnostic Center, UNL, Lincoln, NE. 
our laboratory; 
'Drs. Gustave Delphon and Clinton Jones, DVBS, UNL, Lincoln, NE; 
American Type Tissue Collection, ATCC, Rockville, MD; (Dr J. Ridpath, NADC, USDA, Ames, IA. 
These and previous data confirm the assertion that virtu 
ally all bovine cells and cells from animals of the order 
Artiodactyla, regardless the tissue of origin, are susceptible 
to BVDV infection in vitro. Therefore, the resistance of 
CRIB cells to BVDV infection appears to represent a unique 
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event among in vitro cultured cells from bovine and related 
animal species. 
Crib Cells are Also Resistant to Other Known 
Pestiviruses 
Having determined that CRIB cells were resistant to 
infection by BVDV, we then explored the permissiveness of 
these cells to other virus species in the genus Pestivirus, 
namely Hog Cholera Virus and Border Disease Virus. 
MDBK and PK-15 cells were obtained from the American 
TypeTissue Collection (ATCC) and clone #1 (CRIB-1) was 
used exclusively in hog cholera experiments. Three border 
disease virus (BDV) isolates (Coos Bam, Id. and 31) were 
obtained from the University of California at Davis and the 
other isolate (BDV 264) was obtained from the Veterinary 
Diagnostic Laboratory of the University of Nebraska at 
Lincoln. The two hog cholera virus (HCV) strains (250 and 
9202) were obtained from the National Veterinary Services 
Laboratory at Ames, Iowa. These are standard strains used 
routinely for serum neutralization assays. 
Detection of BDW antigens was performed by indirect 
immunofluorescence (IFA), using a murine anti-pestivirus 
non-structural protein p80 (mab 20.10.6) as primary anti 
body and a FITC-conjugate goat anti-mouse IgG mono 
clonal antibody as secondary antibody. Detection of HCV 
antigens was performed by direct immunofluorescence 
using a goat anti-HCV FITC-conjugate polyclonal antisera. 
CRIB-1 and MDBK cells were inoculated with BDV 
(Coos Bam, Id., 31 or 264) at a m.o.i. of approximately 1 and 
infection was monitored by IFA. MDBK cells served as 
positive control for BDW infection. The inoculation of 
CRIB-1 cells did not resultin production of viral proteins as 
demonstrated by negative immunofluorescence. In contrast, 
approximately 70% of the MDBK cells inoculated with 
BDV were positive by IFA. 
CRIB-1, MDBK and PK-15 cells were inoculated with 
HCV (250 and 9202) at a m.o. i. of 1. Infection was moni 
tored by direct immunofluorescence performed 48 hours 
post-infection. PK-15 and MDBK cells served as positive 
controls for HCV infection. The inoculation of CRIB cells 
with the two isolates of hog cholera virus (HCV) at m.o.i. of 
approximately one did not result in production of viral 
proteins, as demonstrated by direct immunofluorescence 
performed 48 hours post-infection. Approximately 60 to 
70% of PK-15 and MDBK cells were positive for HCV 
antigens in this experiment. 
These results indicate that CRIB cells are resistant to 
infection with BDW and HCV, since no vital proteins are 
detected by IFA following inoculation with these viruses. 
Characteristics of Crib Cells 
1. CRIB Cells are Susceptible to Other Unrelated Viruses 
In order to investigate whether the resistant phenotype 
was BVDV-specific or consequence of a non-specific anti 
viral blocking activity, CRIB cells were inoculated with 
several bovine viruses that are not of the genus Pestivirus. 
CRIB-1 and MDBK cells were infected with approximately 
1 TCIDso of bovine herpesvirus type 1,2 and 4 (BHV-1, 2 
and 4), bovine adenovirus type 3, vesicular stomatitis virus (VSV), bovine parvovirus (BPV), bovine respiratory syn 
cytial virus (BRSV), bovine enterovirus and bovine parain 
fluenza-3 virus (PI-3). Infection with BPV was monitored by 
immunofluorescence 48 hours post-inoculation (hpi) and 
infection with the other viruses was assessed by appearance 
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of cytopathic effect (CPE) 24 to 48 hpi. Supernatant of these 
cultures was harvested and progeny virus production was 
quantitated by infection of bovine testicle cells with serial 
10-fold dilutions and expressed as 50% tissue culture infec 
tious dose (TCIDs)(Reed & Muench, 1956). Plaque forma 
tion by vesicular stomatitis virus (VSV) in MDBK and 
CRIB cells was assayed as described by Wunner. Wunner, 
W. H. (1985), Virology, a practical approach, pp. 79-93 (B. 
W. J. Mahy, Ed., Oxford/Washington, D.C.: IRL Press). 
The outcome of the infection of CRIB cells with each of 
these viruses was compared with that in the parental MDBK 
cells. The course of the infection, cytopathology and yield of 
most of these viruses in CRIB cells did not differ signifi 
cantly from those observed in MDBK cells. Plaques formed 
by VSV and BHV-1 in CRIB cells were morphologically 
similar to those formed in MDBK cells. A significant reduc 
tion in yield of progeny BRSV was observed in CRIB -1 as 
compared with MDBK cells. Nonetheless, the susceptibility 
of CRIB cells to five other bovine viruses indicates that the 
resistant phenotype is due to a specific anti-BVDV property 
rather than to a non-specific viral replication block. 
2.Assays for the Species Origin of CRIB Cells Show that 
CRB Cells are Genuine Bovine Cells 
The ineditism of abovine cell resistant to BVDV infection 
prompted us to investigate whether these cells were indeed 
of bovine origin. That CREB cells are genuine bovine cells 
was confirmed by microsatellite DNAPCR, karyotyping and 
isoenzyme analysis. Microsatellite DNA PCR of CRIB-1 
cells using primers specific for ruminant sequences showed 
a pattern of amplification compatible with bovine or rumi 
nant species, ruling out a possible primate, canine, rodent or 
equine cell contamination which would be BVDV resistant. 
Karyotyping of CREB-1 cells has revealed a modal distri 
bution of chromosomes virtually identical to the parental 
MDBK cells. Chromosomes had typical bovine morphol 
ogy, similar to primary bovine testicle cells at passage 8. 
Moreover, isoenzyme analysis has shown that the gel mobil 
ity of a set of enzymes of CRIB cells is identical of that of 
the parental and other bovine cells. The enzymes analyzed 
were glucose-6-phosphate dehydrogenase (G6PD), lactate 
dehydrogenase (LDH), nucleoside phosphorylase (NP), 
malate dehydrogenase (MD), mannose phosphate isomerase 
(MPI), peptidase B (Pep B) and glutamate oxalacetate 
transaminase (ASTIGOT). The gel mobilities of these 
enzymes reflect species-specific patterns of post-transla 
tional modifications and have been reliable parameters used 
to identify the species origin of cell lines. 
Taken together, these results conclusively show that CRIB 
cells are genuine bovine cells and not a cell contaminant 
from other animal species. 
3. Fusion of CRIB with Bovine Lymphocytes Render 
them Susceptible to BVDV Infection 
Fusion of CRIB cells with bovine lymphocytes (BL-3) to 
generate heterokaryons was performed to address two ques 
tions: (1) is there a dominant negative intracellular block for 
BVDV replication in CRIB cells? and (2) is it possible to 
complement the CRIB resistant phenotype by wildtype gene 
expression? To answer these questions, somatic cell hybrids 
(heterokaryons) were produced by fusion of CRIB cells and 
bovine lymphocytes (BL-3). CRIB-1 cells (10) were fused 
with approximately 10 bovine lymphocytes (BL-3), using 
50% (w/v) polyethylene-glycol(PEG) (MW1450, ATCC) 
according to fusion protocols previously described (Pon 
tecorvo, 1975). After fusion, the cells were seeded in 12 well 
plates, left to attach overnight and unattached cells were 
removed by washing the cultures three times with PBS. 
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Cultures were inoculated with BVDV Singer-cp and VS 
115-ncp (10 TCID50/cell) one to 10 days after fusion and 
infection was monitored by IFA. Production of infectious 
virus by BL-3/CRIB-1 hybrids infected with VS115-ncp 
was assessed by cocultivation with bovine testicle cells as 
described above. PEG-fused CRIB-1 cells and unfused 
cocultures of BL-3 and CRIB cells were used as controls. 
BL-3 cells grow in suspension and can be easily washed out 
from the culture after attachment of CRIB cells. Therefore, 
cells attached to the plastic surface would be either unfused 
CRIB cells or hybrids/heterokaryons that express the CRIB 
phenotype for anchorage-dependent growth. BVDV inocu 
lation of CRIB/BL-3 fused cells at different time points after 
fusion showed a significative number of positive cells. These 
positive cells were detected upon challenge performed up to 
10 days after fusion. Cocultivation of BVDV-inoculated 
hybrids with indicator cells was followed by recovery of 
infectious virus showing that the fused cells support the 
complete viral cycle. In contrast, virus inoculation of control 
CRIB cells subjected to fusion did not result in detection of 
viral proteins or progeny virus. 
These results demonstrated that there is not a negative 
dominant block for BVDV replication in CRIB cells since 
hybrids (or heterokaryons) are susceptible to infection. More 
importantly, they suggested that the resistant phenotype of 
CRIB cells is a recessive trait since expression of genes from 
wildtype cells render them susceptible to BVDV infection. 
4. CRIB Cells are Defective in BVDV Entry and in Entry 
of Other Known Pestiviruses 
(a) BVDV Entry 
The lack of detection of viral proteins following inocu 
lation of CRIB cells with BVD virus first suggested that the 
virus replication block involves an early stage of the vital 
cycle, preceding translation of the input RNA genomes. If 
the resistant phenotype were derived solely from a block in 
the viral entry, bypassing this step would allow productive 
vital replication. We addressed this hypothesis by perform 
ing two sets of experiments: (1) transfection of BVDV RNA 
into CRIB cells, and (2) addition of polyethylene-glycol 
(PEG) to the vital inoculum, trying to overcome a possible 
defect in virus entry. 
(i) BVDV RNA Isolation and Transfection Assays 
Bovine testicle and MDBK cells were infected with 5 
p.fu/cell of Singer-cp and harvested for RNA isolation 20 
hours post infection. CRB-1 and mock-infected MDBK 
cells were processed in parallel for northern blot analysis. 
Total cellular RNA was extracted as previously described 
(Ausubel et al., 1986). Viral RNA was separated from total 
cellular RNA by agarose gel electrophoresis and isolated 
from the gel by adsorption to glass powder. The RNA used 
for transfection consisted of approximately 1 pg of agarose 
gel purified viral RNA and 5 pg of carrier RNA per well. 
Transfection of BVDV RNA was performed in 60% 
confluent CRIB-1 and MDBK cells grown in 12 well plates 
(approximately 6x10 cells/well). Transfection was per 
formed with Lipofectamine Reagent (Gibco BRL, Inc.) 
according to the manufacturer's protocol. Cells treated only 
with lipofectamine or only with RNA were used as controls. 
After 4 hours of incubation with the lipofection mixture, the 
cells were washed with MEM, overlayed with MEM+FHS 
and incubated at 37° C. Cells were observed daily for 
appearance of CPE and indirect immunofluorescence was 
performed 48 and 72 hours post-transfection. Supernatant of 
transfected CRIB cells was harvested at 48 and 72 hours and 
inoculated in bovine testicle cells. The indicator cells were 
tested by IFA 24 hours after inoculation. RNA transfection 
efficiency was monitored by transfection of pSFVI RNA 
10 
15 
20 
25 
30 
35 
40 
45 
50 
55 
60 
65 
12 
which encodes f-galactosidase followed by aX-gal assay 24 
hours later (Ciccarone et al., 1993). 
Liposome-mediated transfection of viral RNA in MDBK 
cells was followed by appearance of characteristic BVDV 
induced CPE 72 hours post-transfection. Indirect immunof. 
luorescence performed at this time confirmed the presence 
of BVDV antigens. Production of infectious BVD virus by 
CRIB cells upon RNA transfection was detected by inocu 
lation of supernatant of these cultures in indicator bovine 
testicle cells. Production of infectious virus by CRIB cells 
after transfection with BVDV RNA was first detected 48 
hours post-transfection. No infectious virus was detected in 
cultures treated with RNA or lipofectamine alone. 
(ii) PEG-Mediated BVDV Infection of CRIB Cells 
Polyethylene-glycol (PEG) is a known enhancer of infec 
tion of tissue culture cells with many viruses (Herrmann et 
al., 1993; Sarmiento et al., 1979; Rohde et al., 1978; Grippon 
et al., 1993; Hoekstra et al. 1989; Asanaka & Lai, 1993; 
Sarmanti et al., 1994; Rohde et al., 1978). Thus, we sought 
to investigate whether PEG could have a similar effect in the 
BVDV/CRIB system. 
CRIB-1 thru CRIB-20 and MDBK cells were trypsinized, 
resuspended in 1 ml of culture medium containing approxi 
mately 10 TCID50/cell of BVD virus (Singer-cp or VS115 
ncp) and 5% PEG (MW 6.000, Carbowax, Fischer Sci.), and 
incubated one hour at 37° C. Cells were sedimented by low 
speed centrifugation, the medium was removed and the cell 
pellet was treated with warm MEM containing 37.5% PEG 
(MW 1.450, ATCC) as described above for cell-cell fusion. 
After treatment, PEG concentration was slowly reduced by 
addition of serum-free MEM, the cells were plated on glass 
coverslips and incubated at 37° C. Production of BVDV 
antigens in these cells was assessed by IFA performed 24 
hours post-inoculation and production of progeny virus was 
monitored by inoculation of supernatant of these cultures in 
indicator bovine testicle cells followed by IFA. 
For quantitation of progeny virus produced by MDBK 
and CRIB cells infected with Singer-cp by PEG-mediated 
infection, following PEG treatment cells were allowed to 
attach to the flask for 6 hours, washed five times with MEM 
to remove extracellular virus and added of culture medium. 
Twenty four hours after infection, the supernatant of the 
cultures was harvested and the amount of virus was quan 
titated as described above. The cells were trypsinized and 
submitted to IFA to estimate the percentage of BVDV 
infected cells. The total number of cells/flask was estimated 
by counting an 1:100 dilution of cell suspension in a 
hematocytometer chamber. 
To determine the fraction of CRIB cells that is susceptible 
to PEG-mediated infection, we performed successive PEG 
mediated infections with BVDV Singer-cp, at 72 hours 
intervals. At 24 hours after each round of infection, a sample 
of the cells was trypsinized and submitted to IFA to estimate 
the percentage of infected cells. The remaining cells were 
cultured for additional 48 hours and reinfected by PEG 
treatment. At the time of the subsequent infection (72 hours 
post infection), a fraction of cells was processed for IFA to 
ensure that the cells infected in the previous round had been 
lysed. These successive rounds of PEG-mediated infection 
were repeated 8 times with the same population of cells. 
Addition of 5% PEG (MW 6000, Fischer Sci. ) to the 
virus inoculum during adsorption at 37° C. led to infection 
of a significant number (approximately 0.5%) of CRIB cells. 
The efficiency of infection was dramatically (up to 10-fold) 
increased when cells were treated with 37.5% PEG (MW 
1450) for one minute after adsorption of virus. Neither 
increasing the time of exposure to 37.5% PEG nor higher 
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PEG concentrations enhanced the infectivity further. Quan 
titation of progeny virus in the supernatant of CRIB cells 
infected with Singer-cp by PEG-mediated infection showed 
that these cells appear to be fully permissive to viral repli 
cation. The yield, expressed as infectious units/infected cell, 
was equivalent to wildtype MDBK cells (30 to 80 TCIDs), 
indicating that replication in individual CRIB cells reaches 
levels comparable to MDBK cells. 
Repeated PEG-mediated infection of the same population 
of CRIB cells with cytopathic BVDV Singer resulted in 
approximately 2-3% infected cells at each round, as dem 
onstrated by IFA performed 24 hours post-infection. Virtu 
ally all the infected cells detected at this time were lysed at 
72 hours, when the subsequent round of infection was 
performed. At each subsequent round of infection, a similar 
fraction of CRIB cells was infected. These results suggest 
that the entire population of CRIB cells is sensitive to 
PEG-mediated BVDV infection at a similar level. 
The results of RNA transfection and PEG-mediated infec 
tion demonstrate that the resistance resides in an early step 
of the viral cycle: CRIB cells are permissive to BVDV gene 
expression and production of infectious progeny virions if 
replication-competent viral genomes are introduced into 
cells. Further studies are being carried out to define which 
step of the entry process is limiting for BVDV infection in 
CRIB cells. 
(b) Entry of Other Pestivirus 
CRIB and MDBK cells were trypsinized, resuspended in 
MEM containing 5% PEG (MW 6000) and approximately 1 
TCIDs/cell of the HCV and BDV isolates, and incubated 
one hour at 37 C. After PEG treatment, cells were resus 
pended in culture medium and incubated at 37° C. for 24 
hours. Immunofluorescence for BDW or HCV antigens was 
performed 24 hours post-infection. 
Inoculation of CRIB cells with HCV and BDW does not 
result in infection, as demonstrated by lack of detection of 
viral protein synthesis by IFA. However, inoculation of these 
viruses in the presence of polyethylene-glycol (PEG) results 
in infection of a significant number of cells. The efficiency 
of infection is maximized when the virus inoculum is 
adsorbed in the presence of 5% PEG (MW 6000), followed 
by treatment with 37.5% PEG (MW 1450). PEG treatment 
has been associated with enhancement of virus infection in 
several viral systems in vitro. Although the exact mechanism 
by which PEG mediates infection is not well understood, it 
is likely enhancing the interactions between virions and the 
cell surface leading to increased internalization of particles. 
The ability of PEG to mediate infection of CRIB cells by 
HCV and BDW suggests that the block for viral replication 
is these cells is at the viral entry. 
5. The Genetic Events Resulting in Resistance have not 
yet been Determined. 
The genetic events that led to the development of the 
resistant phenotype remain to be determined. Two possibili 
ties can be entertained: (1) CRIB cells are derived from 
BVDV and Pestivirus-resistant clones that were already 
present among MDBK cells, or (2) they were generated by 
a multistep selection process following the initial infection. 
In the first case, infection with cytopathic virus has operated 
only as a selective pressure, resulting in the selection of 
resistant clones. Resistant cells, if present among the MDBK 
population, must be at very low frequency since infection 
with cytolytic strains usually results in killing of virtually 
hundred percent of the cells and the few cells that survive 
normally develop a persistent infection. Alternatively, resis 
tant cells have been generated by a multistep selection 
process, during persistent infection, following the initial 
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infection. Evolution of cells through persistent infection 
resulting in reduced permissiveness to viral replication has 
been reported in other viral systems (Ron & Tal., 1986, 
"Spontaneous curing of a minute virus of mice carrier state 
by selection of cells with an intracellular block of viral 
replication.” J. Virol. 58(1):26-30; Kaplan et al., 1989, 
"Isolation and Characterization of Hela cell Lines Blocked 
at Different Steps in the Poliovirus Life Cycle." J. Virol. 
63:43-51; Kaplan & Racaniello, 1991, "Down Regulation 
of Poliovirus Receptor RMA in Hela Cells Resistant to 
Poliovirus Infection.' J. Virol. 65(4): 1829-35; De La Torre 
et al., 1988, "Coevolution of cells and viruses in a Persistent 
Infection of Foot-and-Mouth Disease Virus In Cell Culture.' 
J. Viorl. 62(6):2050-58; Ahmed et al. 1981, "Role of host 
cell in a Persistent Vital Infection: Coevolution of L. Cells 
and Reovirus During Persistent Infection.” Cell 25:325-32). 
Long-term persistent infection of mouse L cells with a 
lymphotropic strain of minute virus of mice resulted in 
spontaneous curing of infection through selection of cell 
clones with an intracellular block to virus replication (Ron 
& Tal, 1986, supra). Hela cells partially resistant to polio 
virus infection due to down-regulation of the virus receptor 
have been obtained through cotransfection of poliovirus 
genomic and subgenomic RNAs (Kaplan at al., 1989, supra; 
Kaplan & Racaniello, 1991, supra). Curing of late-passage 
CI-BHK-Rol cells of foot and mouth disease virus (FMDV) 
by ribavirin treatment resulted in selection of resistant cells 
that have a intracellular block to virus replication (De La 
Torre et al., 1988, supra). Likewise, curing of mouse L cells 
persistently infected with reovirus by specific anti-serum 
resulted in mutant cells that were partially resistant to 
infection with wildtype virus (Ahmed et al., 1981, supra). 
In our experiment, after the initial lyric infection of 
MDBK cells, a few cells survived and gave rise to a 
population of cells persistently infected with BVDV. The 
surviving persistently infected cells alternated periods of 
growth with periods of crisis in which nearly all the cells 
showed vacuolation and died. Therefore, it seems likely that 
mutations occurred during the passaging process which gave 
rise to mutant BVDV/Pestivirus-resistant cells that have 
been selected throughout the course of this persistent infec 
tion. However, we cannot rule out the possibility that a 
resistant cell present in the original culture was simply 
Selected in this process. In any case, the function missing in 
CRIB cells that accounts for the resistance to infection by 
BVDV and other Pestivirus appears not to affect cell viabil 
ity and growth: These cells display a pattern of growth even 
superior to that of the parental MDBK cells. 
6. CRIB Cells are Stable 
We have observed that the resistant phenotype of CRIB 
cells is stable: they have been cultured for over 150 popu 
lation doublings and repeated BVDV inoculation experi 
ments showed no evidence of reversion. Likewise, chemi 
cal-induced mutagenesis has also failed to induce reversion 
to the wildtype phenotype. The frequency of positive cells 
observed after inoculation of BVDV at m.o.i. higher than 50 
has been estimated to be around 10. These occasionally 
infected cells seem to represent random events of infection 
via an alternative virus entry pathway rather than reversion 
to the wildtype phenotype. 
7. The Resistance Exhibited by CRIB Cells is not the 
Result of Viral Interference 
Since CRIB cells originated from cells that survived lytic 
BVD virus infection, interference by residual replicative 
forms of the viral RNA would be an attractive explanation 
for the resistance to subsequent challenge with homologous 
virus. Homologous interference between cytopathic and 
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non-cytopathic BVDV strains is a well documented phe 
nomenon (Gillespie et al., 1962; Shirai et al., 1984). How 
ever, interference between BVD viruses is not absolute: cells 
infected with the ncp biotype can be superinfected with a 
cytopathic virus (Gillespie et al., 1962; Shirai et al., 1984). 
The degree of interference varies among different strains and 
is generally manifested by delayed replication and damp 
ened cytopathology by the superinfecting virus (Shirai et al., 
1984). The interference is believed to restrict RNA replica 
tion and assembly of progeny virions, but appears to have no 
effect on virus entry. CRIB cells display a degree of resis 
tance to viral infection that greatly exceeds the levels 
interference resulting from homologous virus infection. 
RNA transfection and PEG-mediated infection results in 
efficient replication of BVDV in CRIB cells as demonstrated 
by the amount of progeny virus recovered from the Super 
natant of these cultures. These findings suggest that the 
intracellular milieu of CRIB cells is fully permissive to 
BVDV replication if the virus entry block is bypassed and do 
not support a homologous interference mechanism as the 
basis for the resistance. Nonetheless, we sought to eliminate 
interference as a mechanistic possibility by investigating the 
presence of BVDV genome and gene products in these cells. 
Using extremely sensitive methods of detection, described 
above, we concluded that infectious virus or viral Subprod 
ucts are absent from CRIB cells; or if present, the levels 
could not account for the resistant phenotype of CRIB cells. 
8. The Resistance Exhibited by CRIB Cells is not the 
Result of a Non-Specific Anti-Viral Factor 
The ability of many viruses belonging to several divergent 
taxonomic groups to replicate in CRIB cells demonstrates 
that the resistant phenotype is neither a consequence of the 
expression of anonspecific anti-viral factor nor a result from 
a broad metabolic defect in the physiologic mechanisms 
required for virus replication. Furthermore, the capacity of 
different bovine viruses to replicate in CRIB cells points out 
for a potential use of these cells in virology research, 
diagnostics and vaccine production. 
The susceptibility of cells derived from fusion of CRIB 
and bovine lymphocytes (BL-3) to BVDV and other Pes 
tivirus infection allows two interpretations: first, the detec 
tion of positive cells (heterokaryons) upon early post-fusion 
inoculation (1 to 3 days) demonstrate the absence of nega 
tive transdominant block for BVDV replication in CRIB 
cells; second, the detection of positive cells (heterokaryons/ 
hybrids) upon late inoculation post-fusion (7 to 10 days) 
suggests that the defect in CRIB cells can be complemented 
by expression of wildtype BL-3 genes. In other words, the 
expression of wildtype genes in the hybrids (heterokaryons) 
provides the factor(s) missing in CRIB cells for suscepti 
bility to BVDV infection. Inoculation of BVDV up to 10 
days after fusion was followed by detection of infected 
hybrids by IFA and detection of progeny virus by coculti 
vation. It is likely that susceptibility to infection was derived 
from the expression of wildtype genes from the BL-3 rather 
than from the presence of proteins from the original fusion 
partners. Experiments to obtain stable CRIB/BL-3 hybrid 
clones are being carried out and will help in the understand 
ing of the genetic defects behind the resistant phenotype. 
9. The Resistance Exhibited by CRIB Cells Results in a 
Block to Viral Entry into the Cells 
The ability of BVD virus to replicate in CRIB cells upon 
RNA transfection and PEG-mediated infection indicates that 
the block resides at an early stage of the viral cycle preced 
ing translation of the open reading frame and RNA replica 
tion. The altered function likely compromises one or more of 
the early steps of the viral cycle, i.e. as attachment, fusion, 
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penetration, uncoating or intracellular transport. Adsorption 
of the virus inoculum in the presence of PEG followed by 
treatment with 37.5% PEG leads to an increase in the 
frequency of BVDV infection in CRIB cells from 10 to 
about 5%. Thus, the PEG treatment brings about a 4.3 logo, 
increase in the efficiency of BVDV infection in CRIB cells. 
Testing of several different clones of CRIB cells does not 
alter the overall frequency of infection, ruling out any 
clonally-linked propensity to PEG-mediated susceptibility 
to infection. To determine if only a 5% fraction of the CRIB 
cell population is susceptible to BVDV by PEG treatment, 
we designed an experiment to kill all PEG-mediated BVDV 
susceptible cells and then use the surviving cells to perform 
another PEG-mediated infection. We sequentially repeated 
the PEG-mediated infection with BVDV Singer-cp in the 
same population of cells up to 8 times at intervals of 72 
hours. At each cycle of infection, approximately 2 to 3% of 
the cells were infected and lysed, as demonstrated by IFA 
preformed 24 and 72 hours post-infection. Subsequent virus 
inoculations led to a similar number of infected cells. From 
these data we conclude that the surviving cell population in 
CRIB cultures infected with BVDV Singer-cp by PEG are just as sensitive to subsequent reinfection, indicating that the 
limiting factor is the PEG-mediated infection process. 
Quantitation of the progeny virus produced by CRIB cells 
infected by PEG-mediated infection suggests that BVDV 
replicates efficiently in the population of cells that get 
infected. The amount of infectious virus present in the 
supernatant 24 hours after infection is consistent with effi 
cient viral replication in a few (2 to 3%) cells. From these 
experiments, we conclude that CRIB cells are fully permis 
sive to BVD virus replication if the initial block is bypassed. 
The exact mechanism by which PEG is mediating infec 
tion in CRIB cells, however, is still not clear. Polyethylene 
glycol treatment has been correlated with a strong enhance 
ment of virus binding (Gripon et al., 1993; Hoekstra et al., 
1989) and with virus-cell membrane fusion (Hoekstra et al., 
1989; Asanaka et al., 1993; Sarmiento et al., 1979; Fehler et 
al., 1992; Herrmann et al., 1993; Rohde et al., 1978). PEG 
has been shown to induce fusion of Sendai virus with 
erythrocyte ghosts (Hoekstra et al., 1989), to increase effi 
ciency of hepatitis B virus (HBV) infection of hepatocytes 
(Gripon et al., 1993; ASV meeting), to allow mouse hepatitis 
virus (MHV) (Asanaka et al., 1993) and avian sarcoma virus 
(Rohde et al., 1978) to initiate infection in cells lacking 
specific virus receptors. Herpes simplex virus type 1 (HSV 
1) and bovine herpes virus type 1 (BHV-1) mutants devoid 
of envelope glycoproteins involved in virus penetration are 
able to efficiently bind to cells but only initiate infection 
upon addition of PEG (Fehler et al., 1992; Sarmiento et al., 
1979). PEG has been shown to enhance both binding and 
fusion of influenza virus with erythrocytes (Herrmann et al., 
1993) and has been used to enhance detection of HIV in 
serum of seropositive patients (Sarmanti et al., 1994). Fur 
thermore, we have observed that adsorption of BVDV, 
vesicular stomatitis virus (VSV) and bovine respiratory 
syncytial virus (BRSV), in the presence of 5% PEG 
increases plaquing efficiency and virus yield in different cell 
lines up to 10-fold. Although PEG may be operating by a 
different mechanism in each viral system, it is likely that a 
common feature includes an enhancement of the interactions 
between virions and cells. 
PEG is likely mediating BVDV infection of CRIB cells by 
favoring interactions between virions and the cell membrane 
resulting in a productive pathway of BVDV entry. Support 
ing this hypothesis, we have observed that PEG-mediated 
BVDV infection of CREB cells is dramatically reduced by 
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inhibitors of endocytosis (phenylarsine oxide) and by agents 
that prevent endosomal acidification (chloroquine, NH4Cl) 
(Flores et al. manuscript in preparation). In other words, 
PEG-mediated BVDV infection of CRIB cells is dependent 
on functional endocytosis and subsequent endosome acidi 
fication. These data suggest that PEG is favoring infection 
through the physiological pathway of BVD virus entry 
rather than creating a non-physiological mechanism (e.g. 
penetration by direct fusion at the cell surface). Based on 
these data, it can be speculated that PEG is acting either by 
increasing binding to cell surface molecules or by favoring 
a step subsequent to virus attachment that is necessary for 
virus internalization in CRIB cells. 
The wide range of cell lineages that support the replica 
tion of BVDV in vitro suggests that the host factors required 
for viral replication are quite ubiquitous among these cells. 
The fact that BVDV replication in vivo is restricted to a few 
cell populations suggests that the factors required for virus 
replication are differentially expressed in vivo and in vitro. 
It is conceivable that CRIB cells lack a function at the cell 
surface that is responsible for the BVDV resistant pheno 
type. This function appears not to be essential for cell growth 
in normal culture conditions, since CRIB cells display a 
pattern of growth undistinguishable from that of the parental 
cells. Thus, the factor(s) missing in CRIB cells may lead to 
clues into the tissue tropism of BVDV. 
Previous observations have suggested that different 
BVDV strains may use alternative cell receptors to initiate 
infection in bovine cells. Nonetheless, CRIB cells were 
selected by infection with a single virus isolate (Singer) and 
display resistance to all BVDV isolates tested to date. These 
findings suggest that a common cell surface molecule is 
required for all these strains to initiate infection in MDBK 
cells. Moreover, it is apparent that the molecule in question 
is required by all known viruses of the genus Pestivirus. 
Thus, the cell entry mechanism of Pestiviruses may display 
substantial levels of conservation. The identity of this mol 
ecules) and whetheritis involved in initial attachment of the 
virions or in a subsequent step in the internalization process 
are currently under investigation. Characterization of this 
factor(s) will be an important step towards the understanding 
of the early interactions of BVDV with cells as well as the 
molecular basis of virus tropism and host range. 
The Utility of Crib Cells 
Pestiviruses, especially BVDV, are common contami 
nants of fetal bovine serum used as growth promoter for 
cultured cells. As a consequence, many cell lines of different 
species have been found contaminated with BVDV. Inad 
vertent BVDV contamination of tissue culture cells may 
interfere with virology studies as well as with virology 
diagnosis. Furthermore, presence of adventitious BVDV in 
modified-live virus vaccines produced in tissue culture cells 
may lead to disastrous consequences for vaccinated animals. 
The consequences of inadvertent BVDV contamination of 
animal virus vaccines have been repeatedly reported: (i) 
mortality of piglets born to dams vaccinated with a HCV 
vaccine has been attributed to the presence of contaminant 
BVD virus; (ii) abortion in cows vaccinated with an IBR/ 
BRSP/PI-3 live vaccine has been associated with vaccine 
contamination with a non-cytopathic BVDV strain; (iii) 
BVDV contamination of a Pseudorabies virus vaccine has 
been associated with high mortality in vaccinated piglets. 
Surveys for BVDV contamination in animal virus vaccines 
commercially available in the U.S. have revealed contami 
nation levels as high as 8%. The inadvertent contamination 
10 
15 
20 
25 
30 
35 
40 
45 
SO 
55 
60 
65 
18 
of cell cultures with BVDV virus also poses a problem for 
virology diagnosis; contamination of FBS used in a test 
system may lead to false-positive Pestivirus isolation by 
Immunocytochemical assays or other techniques. Also, 
inadvertent presence of BVDV in culture cells used for viral 
isolation may lead to false-negative isolation due to inter 
ference. Alternatively, BVDV contamination of cell cultures 
may interfere with other aspects of virology research. 
CRIB cells combine several desired properties of a suit 
able cell line for different applications: (i) they are derived 
from MDBK cells, one of the best characterized animal cell 
lines, (ii) CRIB cells are mutant MDBK cells that retain 
most of their desirable properties; (iii) CRIB cells are 
susceptible to all other bovine viruses tested so far; (iv) 
CRIB cells are resistant to BVDV and other Pestiviruses and 
therefore do not amplify any Pestivirus potentially present in 
contaminated serum or culture medium. These characteris 
tics point out potential uses of CRIB cells for: 
1. Production of modified-live virus vaccines for other 
bovine viruses: the use of CRIB cells as a system for 
growth of these viruses (e.g. rotavirus, respiratory 
syncytial virus) eliminates the probability of amplifi 
cation of any potential contaminating BVDV intro 
duced inadvertently. The same principle applies to the 
production of any other biological product that requires 
the use of a cell line of bovine origin. 
2. Use of CRIB cells as a differential system for viral 
isolation in virology diagnosis: CREB cells are as 
susceptible as the parental MDBK cells to otherbovine 
viruses of veterinary clinical relevance. MDBK cells 
have been largely used for viral isolation in veterinary 
diagnostic. 
3. The use of CRIB cell in virology research ensures that 
a viral system developed using these cells will be free 
of the potential adverse effects of adventitious Pestivi 
rus contamination. 
4. The identification of the cellular factor(s) responsible 
for the resistance of CRIB cells to infection with 
Pestiviruses by using these cells for genetic comple 
mentation analysis. The expression-cloning of the 
BVDV factor involved in BVDVentry into cells could 
be carried out using these cells. 
What is claimed is: 
1. An isolated clonal cell line, derived from a culture of 
Madin-Darby Bovine Kidney cells (MDBK cells), said 
clonal cell line having the characteristics of the deposit made 
with the American Type Culture Collection SD 1831, 
together with those cultures and subclones of said clonal cell 
line which express the in vitro resistance to bovine viral 
diarrhea virus characteristic of the deposited clonal cell line. 
2. The isolated clonal cell line of claim 1, said cell line 
being resistant to in vitro infection by Bovine Viral Diarrhea 
Virus, Hog Cholera Virus, and Border Disease Virus, which 
resistance can be overcome by fusion of the cells with 
bovine lymphocyte cells containing wild type genes or by 
transfection with viral RNA, and those cultures and sub 
clones of said clonal cell line which express resistance to in 
vitro infection by Bovine Viral Diarrhea Virus and all other 
known Pestiviruses, which resistance can be overcome by 
fusion of the cells with bovine lymphocyte cells containing 
wild type genes or by transfection with viral RNA. 
3. An isolated clonal cell line derived from a culture of 
Madin-Darby Bovine Kidney Cells (MDBK cells), and 
those cultures and subclones of said clonal cell line, con 
sisting of cells characterized as follows: 
(a) the cells are resistant to in vitro infection by all 
biotypes and strains of Bovine Viral Diarrhea Virus 
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(BVDV) Hog Cholera Virus (HCV), and Border Dis 
ease (BDV); 
(b) the cells are susceptible to infection by other unrelated 
viruses that replicate in bovine kidney cells; 
(c) the cells have a genetic defect which is both stable and 
recessive and which confers resistance to in vitro 
BVDV infection at the level of viral entry, and not by 
intracellular block to viral replication; 
(d) the cells have an intracellular milieu fully permissive 
to replication of BVDV and other viruses that gain 
entry into the cells; and 
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(e) the genetic defect conferring resistance to in vitro 
BVDV infection does not impair cell growth and 
viability. 
4. The isolated clonal cell line of claim 3, wherein said 
cells are susceptile to bovine herpes type 1, 2 and 4, bovine 
adenovirus type 3, vesicular stomatitis virus, bovine par 
vovirus, bovine respiratory syncytial virus, bovine enterovi 
rus and bovine parainfluenza virus. 
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